Andrew M. Wolf, MD (Chair)
Associate Professor of Medicine, University of Virginia School of Medicine Program Director for the UVA Internal Medicine Residency Program

Primary Care Physician, Health Services

Dr. Andrew Wolf is a general internist and currently Associate Professor of Medicine at the University of Virginia School of Medicine in Charlottesville, Virginia. He serves as Associate Program Director for the UVA Internal Medicine Residency Program and directs its primary care track. He earned his BA (magna cum laude) from Harvard College and MD from UVA (Alpha Omega Alpha Honor Medical Society). He completed his internal medicine residency at Brown University/Rhode Island Hospital.

Dr. Wolf’s areas of expertise are cancer screening and medical education. His particular research interest is in enhancing patient involvement in cancer screening decisions. For his educational accomplishments, he has won 16 teaching awards, including the UVA School of Medicine Master Educator Award and has achieved the “Best Doctors in America” distinction for 4 of the past 8 years.

Dr. Wolf has been involved with guideline development with the American Cancer Society (ACS) since 2001. He chaired the ACS Prostate Cancer Advisory Committee that developed the 2010 prostate cancer screening guideline, as well as the Guideline Development Group workgroup for the colorectal cancer screening guideline update in 2018.

Kevin C. Oeffinger, MD, FASCO (Past Chair)
Duke University / Duke Cancer Institute (DCI) Director, DCI Center for Onco-Primary Care Director, DCI Supportive Care and Survivorship Center

Primary Care, Cancer Screening in Childhood Cancer Survivors

Kevin Oeffinger, MD, is a family physician, a member of the Duke Cancer Institute (DCI), the founding Director of the DCI Center for Onco-Primary Care, and Director of the DCI Supportive Care and Survivorship Center. He has a long-standing track record of NIH-supported research in cancer screening and survivorship and has served in a leadership capacity in various cancer- and primary care-focused national committees and organizations, including the American Cancer Society, the American Society of Clinical Oncology, and the American Academy of Family Physicians.

Dr. Oeffinger is the past chair of the Guideline Development Group (GDG). He chaired the GDG workgroup that developed the 2015 breast cancer screening guideline update.

Timothy R. Church, PhD
Professor Emeritus, University of Minnesota School of Public Health

Biostatistician, Epidemiologist

Professor Timothy R. Church, PhD, is a tenured professor at the University of Minnesota School of Public Health and has been on faculty since 1996. He conducts very large studies of disease prevention and etiology, including: the Minnesota Colon Cancer Control Study; the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial; the National Colonoscopy Screening Trial; the Lung Screening Study; the National Lung Screening Trial; the Minnesota-Wisconsin Men’s Health Study; and the Colon Cancer Family Registry. Additionally, he conducted numerous studies on HIV/AIDS, cardiac arrhythmias, and occupational violence and injury. At Medtronic, Inc, he conducted over 50 clinical trials of pacemaker and defibrillator systems. He has over 130 research publications on varied topics such as: cancer screening; risk stratification; statistical models of biological processes and diagnosis; clinical trial and epidemiologic methodology; biomarkers of carcinogen exposure to lung and cancers risk; and validation of epigenetic biomarkers for early detection.

Dr. Church sits on several national and international advisory boards, including the National Lung Screening Trial Executive Committee, the PROSPR Consulting Committee, and the American Cancer Society’s Guideline Development Group. He serves on the editorial board of the Journal of the National Cancer Institute and reviews for numerous high-profile medical, statistical, and scientific journals. He also serves as a reviewer for the National Institutes of Health, the Department of Defense, the Environmental Protection Agency, the Commonwealth of Pennsylvania, and the Minnesota Department of Health. He currently chairs two Data and Safety Monitoring Boards (DSMB), and is a member of many other DSMBs, including for the US Department of Veterans Affairs and the medical device industry. He sat on a University of MN Institutional Research Board for 10 years and is a consultant to several large national and international projects addressing chronic disease screening and prevention.

Elena Elkin, PhD, MPA
Professor, Health Policy and Management, Columbia University Irving Medical Center

Researcher in Health Policy & Decision Sciences

Dr. Elena Elkin studies determinants of cancer screening, treatment, and outcomes using population-based observational data analysis, decision analysis, and surveys. Much of her research has addressed screening mammography, including the development and evaluation of a web-based tool to help women in their 40s decide when to start and how often to have screening mammograms, and studies of geographic access to mammography. She also investigates the cost and cost-effectiveness of clinical, behavioral, and educational interventions for cancer patients and survivors in numerous NCI-funded trials. Dr. Elkin is a Professor of Health Policy and Management at Columbia University’s Mailman School of Public Health, where she leads the certificate in Comparative Effectiveness and Outcomes Research. She is also a member of Columbia’s Herbert Irving Comprehensive Cancer Center.

Previously, Dr. Elkin was a faculty member in the Department of Epidemiology and Biostatistics at Memorial Sloan Kettering Cancer Center and in the Department of Healthcare Policy and Research at Weill Cornell Medical College. In 2016-2017, she served as a Robert Wood Johnson Foundation Health Policy Fellow, working in the office of US Senator Sheldon Whitehouse (RI). She is currently a member of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC).

Dr. Elkin received her PhD in Health Policy, with a concentration in Decision Sciences, from Harvard University. She has a MPA in Health Policy and Management from New York University and a BS in Communications from Cornell University.

Ruth Etzioni, PhD
Professor of Public Health Sciences Division, Fred Hutchinson Cancer Center

Biostatistician, Epidemiologist

Dr. Ruth Etzioni’s work focuses on statistical and computer modeling for policy development. A critical component of this work is the estimation of disease natural history and progression, which then forms a substrate for modeling comparative- and cost-effectiveness of alternative interventions. Dr. Etzioni’s models of disease have been used to estimate the lifetime probabilities of prostate cancer and its outcomes, the extent of associated overdiagnosis, and quantify the roles of screening and changes in receipt of initial therapies in mortality declines. She serves on three national panels on prostate cancer early detection. Her work on prostate cancer modeling is done as part of the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) consortium, for which she serves on the steering committee and is the Principal Investigator on the Prostate Cancer Coordinating Center.

Elizabeth T.H. Fontham, MPH, DrPH
Founding Dean of Louisiana State University Health Sciences Center School of Public Health Emeritus Professor of Epidemiology, LSUHSC School of Public Health


Dr. Elizabeth (Terry) Fontham is Founding Dean of Louisiana State University Health Sciences Center School of Public Health (LSUHSC SPH) and Emeritus Professor of Epidemiology. She also holds a joint appointment in the LSUHSC School of Medicine Department of Pathology. She joined the faculty of LSUHSC in 1979. Dr. Fontham’s area of expertise is cancer epidemiology, with a particular interest in tobacco- and nutrition-related cancers and in gastric cancer premalignant lesions. Dr. Fontham is author of more than 170 publications in peer-reviewed scientific journals, book chapters, and monographs. Her current research includes innovative approaches to cervical cancer screening in hard-to-reach women, as well as the long-term health effects related to exposures as a result of the Gulf of Mexico Oil Spill. For her outstanding work in the field of lung cancer epidemiology, Dr. Fontham has received the Alton Ochsner Award relating smoking and health from the American College of Chest Physicians and the Ochsner Clinic. In addition to this and other awards, she is the recipient of funding grants from the National Cancer Institute and the US Department of Defense. She served as President of the American Cancer Society in 2009.

Dr. Fontham earned her BA from the Louisiana State University in Chemistry and MPH and DrPH in Epidemiology from Tulane University School of Public Health and Tropical Medicine.

Carmen E. Guerra, MD, MSCE, FACP
Associate Professor of Medicine, University of Pennsylvania Perelman School of Medicine Associate Director, Diversity and Outreach, UPenn Abramson Cancer Center

Primary Care Physician, Health Equity and Cancer Control Researcher

Dr. Carmen Guerra is the Ruth C. and Raymond G. Perelman Associate Professor of Medicine at the Perelman School of Medicine of the University of Pennsylvania. Dr. Guerra is the Associate Director of Diversity and Outreach of the Abramson Cancer Center.

At the Abramson Cancer Center, Dr. Guerra founded and currently co-directs two patient navigation programs focused on the underserved populations of Philadelphia, which have increased access to cancer screenings. She also directs the Abramson Cancer Center Office of Diversity and serves as Vice Chair for Diversity and Inclusion in the Department of Medicine.

Dr. Guerra completed her MD at the University of Rochester School of Medicine and Dentistry, and her internship and residency in internal medicine at the Strong Memorial Hospital. She also completed a MS in Clinical Epidemiology at the University of Pennsylvania. Dr. Guerra is board-certified internist and a fellow of the American College of Physicians.

Dr. Guerra is also a practicing primary care physician and a health equity and cancer control researcher. She is the recipient of several NIH and American Cancer Society (ACS) grants that have supported her research to better understand and overcome barriers to cancer screening. She is also the recipient of the Amos Medical Faculty Development Program fellowship from the Robert Wood Johnson Foundation. Dr. Guerra is a current member of the National Board of Directors for the ACS. Dr. Guerra also co-chairs the Diversity, Equity and Inclusion committee for the ACS.

Rebecca B. Perkins, MD, MSc
Professor, Obstetrics & Gynecology, Boston University School of Medicine

Primary Care Physician, Research in Cervical Cancer Control & Prevention

Dr. Perkins is a Professor of Obstetrics and Gynecology at Boston University School of Medicine and Boston Medical Center. Her career is dedicated to reducing health disparities in cervical cancer. Her current research focuses on improving utilization of HPV vaccination and cervical cancer screening guidelines. Dr. Perkins is currently working on national projects related to HPV vaccination and cervical cancer prevention with the American Cancer Society (ACS), Centers for Disease Control, Health Resources and Services Administration, NCI, and American College of Obstetricians and Gynecologists. She currently co-chairs the ACS National HPV Vaccination Roundtable. She was co-chair and one of the lead authors of the 2019 American Society for Colposcopy and Cervical Pathology’s Risk-Based Management Consensus Guidelines. She co-chaired the President’s Cancer Panel Cervical Cancer Subcommittee, and is currently co-chairing the Enduring Consensus Cervical Cancer Screening and Management Guidelines. She is also working with the NCI on a multi-country project related to cervical cancer prevention in resource-limited settings.

Ya-Chen Tina Shih, PhD
Professor and Chief of Section, Cancer Economics and Policy, University of Texas, MD Anderson Cancer Center Professor, Cancer Treatment and Research, UT MDACC

Health Economist

Dr. Shih is currently Professor and Chief of Section of Cancer Economics and Policy, Department of Health Services Research at the University of Texas MD Anderson Cancer Center (UT MDACC). She also holds Hubert L. and Olive Stringer Professorship for Cancer Treatment and Research at UT MDACC. Prior to joining MD Anderson, she was at Department of Medicine, University of Chicago. At the University of Chicago, she was also the Director of the Program in the Economics of Cancer, Affiliated Faculty at the Center for Health and the Social Sciences, and Member of the Comprehensive Cancer Center. She is an Associate Editor for JNCI and is on the editorial board of PharmacoEconomic, Value in Health, and JCO Oncology Practice. In addition, she had served as a forum member on the National Cancer Policy Forum at the National Academies of Medicine.

Dr. Shih is a widely published author of more than 250 papers in peer-reviewed scientific journals and has co-authored 7 book chapters. Her current research includes studying the impact of technology diffusion in the costs and outcomes of cancer, evaluating the cost-effectiveness of various policy, behavioral, and medical interventions for cancer, and exploring methodological issues in health services research. Dr. Shih has received the E. Lee Walker Imagination Award from the Lance Armstrong Foundation. In addition, she is the recipient of the 2005 Medstate MarketScan Award, 1999 J. Warren Perry Distinguished Author Award, and 2019 Texas Business Women’s Award, UT MDACC. In addition to awards, she is the recipient of funding grants from the NCI and the National Human Genome Research Institute at the NIH, the Agency for Healthcare Research and Quality (AHRQ), the American Cancer Society the Alliance Foundation, the Lance Armstrong Foundation, the Robert Wood Johnson Foundation, and the Chiang Ching-Kuo Foundation for International Scholarly Exchange.

Dr. Shih earned her BA from the National Taiwan University, MA from the National Tsing-Hua University in Taiwan, and PhD from the Department of Economics, Stanford University.

Louise C. Walter, MD
Professor of Medicine and Chief, Division of Geriatrics, University of California San Francisco Associate Director, UCSF Clinical and Translational Science Institute Section Chief, Geriatrics, VA San Francisco Health Care System

Health Services, Geriatrics

Dr. Louise Walter is a Professor of Medicine and Chief of the Division of Geriatrics at the University of California, San Francisco (UCSF). In addition, she is a geriatrician and Section Chief for Geriatrics at the VA San Francisco Health Care System as well as Director of their Geriatrics Health Services Research & Development Program. She is also Associate Director of the UCSF Clinical and Translational Science Institute (CTSI) K Scholars Program and leads the Research Education Core for the UCSF Claude D. Pepper Older Americans Independence Center.

Dr. Walter’s major research interests focus on prognostication and cancer screening in older persons. She has a particular interest in studying the importance of life expectancy, rather than age, in determining real-world risks and benefits of cancer screening in older adults.

Dr. Walter has more than 120 papers in peer-reviewed scientific journals and has co-authored several book chapters focused on preventive services for older adults. Her current research is focused on the juxtaposition of lag-time-to-benefit of preventive services and life expectancy to help individualize screening decisions. For her research accomplishments, she was elected into the American Society for Clinical Investigation in 2012.

Dr. Walter completed her undergraduate work and medical school at Stanford University. She completed an internal medicine residency and a geriatrics fellowship at UCSF.

Abbe Herzig, PhD
Diversity, Equity, and Inclusion Consultant Principal, AHHerzig Consulting

Patient Representative

Dr. Abbe Herzig is a diversity, equity, and inclusion consultant, providing data interpretation and communication expertise for expert and non-expert audiences, as well as action planning for DEI issues in education and research. Previously, she was the Director of Education in the Division of Government Relations of the American Mathematical Society (AMS). In prior roles she served as a staff consultant at Treo Solutions, a healthcare analytics company in Troy, NY. She worked as a statistician for Consumer Reports for almost 30 years, the last 5 of which were in the Consumer Reports Health Ratings Center. While a faculty member in the Education Schools of Rutgers University and at the University at Albany, her research agenda emphasized equity, diversity, and social justice in mathematics education. She has taught graduate courses on research methodology and in pedagogy for teachers of K-12 mathematics, as well as mathematics and statistics at the high school, undergraduate, and graduate levels. Through her consulting, grants, academic research, and other professional experience, Dr. Herzig has served as a resource to researchers, policy analysts, writers and editors, and consumer advocates in the interpretation and communication of data and information. In addition to her doctorate in Curriculum and Instruction, Dr. Herzig has graduate degrees in both statistics and mathematics.